ESMO Resilience Task Force recommendations to manage psychosocial risks, optimise well-being, and reduce burnout in oncology.

Humans Burnout, Professional / prevention & control Medical Oncology / standards Advisory Committees Health Personnel / psychology Resilience, Psychological Europe
burnout oncology professionals psychosocial risk resilience well-being

Journal

ESMO open
ISSN: 2059-7029
Titre abrégé: ESMO Open
Pays: England
ID NLM: 101690685

Informations de publication

Date de publication:
Oct 2024
Historique:
received: 10 02 2024
revised: 10 06 2024
accepted: 10 06 2024
medline: 27 10 2024
pubmed: 27 10 2024
entrez: 26 10 2024
Statut: ppublish

Résumé

Burnout in health care professionals (HCPs) results from exposure to psychosocial risks at work. Left unaddressed, burnout can lead to chronic health problems, increased staff turnover, reduced work hours, absenteeism, and early retirement from clinical practice, thus impacting patient care. The European Society for Medical Oncology (ESMO) Resilience Task Force (RTF) was established in December 2019 to support the well-being of oncology HCPs globally. This ESMO RTF position paper aims to provide a set of recommendations to optimise well-being and mitigate burnout in oncology, and to help individuals and institutions maintain the delivery of optimal cancer care. Recommendations were developed by a diverse multinational panel of interprofessional experts based on the key findings from three previously reported ESMO RTF surveys. Several recurrent work-related psychosocial risks in oncology were identified; in particular, concerns about workload and professional development. The need for flexible work patterns, continued use of virtual resources, well-being resources, and targeted support for at-risk groups were highlighted as key considerations to safeguard HCPs' health and prevent burnout. In total, 11 recommendations relating to three priority themes were developed: (i) information and training; (ii) resources; (iii) activism and advocacy. Optimising the well-being of oncology HCPs is essential for the provision of high-quality, sustainable care for patients globally. The ESMO RTF will continue its mission and is rolling out several initiatives and activities to support the implementation of these recommendations.

Sections du résumé

BACKGROUND BACKGROUND
Burnout in health care professionals (HCPs) results from exposure to psychosocial risks at work. Left unaddressed, burnout can lead to chronic health problems, increased staff turnover, reduced work hours, absenteeism, and early retirement from clinical practice, thus impacting patient care. The European Society for Medical Oncology (ESMO) Resilience Task Force (RTF) was established in December 2019 to support the well-being of oncology HCPs globally. This ESMO RTF position paper aims to provide a set of recommendations to optimise well-being and mitigate burnout in oncology, and to help individuals and institutions maintain the delivery of optimal cancer care.
DESIGN METHODS
Recommendations were developed by a diverse multinational panel of interprofessional experts based on the key findings from three previously reported ESMO RTF surveys.
RESULTS RESULTS
Several recurrent work-related psychosocial risks in oncology were identified; in particular, concerns about workload and professional development. The need for flexible work patterns, continued use of virtual resources, well-being resources, and targeted support for at-risk groups were highlighted as key considerations to safeguard HCPs' health and prevent burnout. In total, 11 recommendations relating to three priority themes were developed: (i) information and training; (ii) resources; (iii) activism and advocacy.
CONCLUSION CONCLUSIONS
Optimising the well-being of oncology HCPs is essential for the provision of high-quality, sustainable care for patients globally. The ESMO RTF will continue its mission and is rolling out several initiatives and activities to support the implementation of these recommendations.

Identifiants

DOI: 10.1016/j.esmoop.2024.103634 PMID: 39461774
pubmed: 39461774
pii: S2059-7029(24)01403-0
doi: 10.1016/j.esmoop.2024.103634
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103634

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

K H J Lim (KHJ)

Cancer Dynamics Laboratory, The Francis Crick Institute, London; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.

K Kamposioras (K)

Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.

E Élez (E)

Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.

J B A G Haanen (JBAG)

Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

C Hardy (C)

Division of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, UK.

K Murali (K)

Victorian Clinical Genetics Services & Murdoch Children's Research Institute, The Royal Children's Hospital, Melbourne, Australia.

M O'Connor (M)

Breast Cancer Centre, University Hospital Waterford, Waterford, Ireland.

C Oing (C)

Translational and Clinical Research Institute, Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK; Mildred Scheel Cancer Career Centre, University Cancer Centre Hamburg, University Medical Centre Eppendorf, Hamburg, Germany.

K Punie (K)

Department of Medical Oncology, Sint-Augustinus Hospitals, Wilrijk.

E de Azambuja (E)

Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium.

J Y Blay (JY)

Department of Medical Oncology, Centre Léon Bérard, Lyon; Department of Medical Oncology, Université Claude Bernard, Lyon, France.

S Banerjee (S)

Gynaecology Unit, The Royal Marsden NHS Foundation Trust, London; Division of Clinical Studies, The Institute of Cancer Research, London, UK. Electronic address: susana.banerjee@rmh.nhs.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › ESMO Resilience Task Force recommendations to...
questionsmedicales.fr › Phénomènes psychologiques › Stress psychologique › Épuisement psychologique › Épuisement professionnel › ESMO Resilience Task Force recommendations to...
questionsmedicales.fr › Professions de santé › Médecine › Médecine interne › Oncologie médicale › ESMO Resilience Task Force recommendations to...
questionsmedicales.fr › Organisations et économie des soins de santé › Contrôle social formel › Processus politique › Comités consultatifs › ESMO Resilience Task Force recommendations to...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Personnel de santé › ESMO Resilience Task Force recommendations to...
questionsmedicales.fr › Phénomènes psychologiques › Résilience psychologique › ESMO Resilience Task Force recommendations to...
questionsmedicales.fr › Régions géographiques › Europe › ESMO Resilience Task Force recommendations to...